Whole genome sequencing—spelling out all 3 billion letters in the human genome—"is an obvious and powerful method for advancing our understanding of pancreatic cancer,” according to a new study from TGen, Mayo Clinic and Scottsdale Healthcare published today. The Translational Genomics Research Institute (TGen) demonstrated that the use of WGS “represents a compelling solution to obtaining detailed molecular information on tumor biopsies in order to provide guidance for therapeutic selection,” concluded the study published by the journal PLOS ONE.
